Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors

NCT07750132 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SM2275

Sponsor

Beijing StarMab Biomed Technology Ltd